Ilaria Iacobucci

14.3k total citations · 1 hit paper
165 papers, 3.7k citations indexed

About

Ilaria Iacobucci is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ilaria Iacobucci has authored 165 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Hematology, 73 papers in Genetics and 65 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ilaria Iacobucci's work include Chronic Myeloid Leukemia Treatments (89 papers), Chronic Lymphocytic Leukemia Research (64 papers) and Acute Lymphoblastic Leukemia research (64 papers). Ilaria Iacobucci is often cited by papers focused on Chronic Myeloid Leukemia Treatments (89 papers), Chronic Lymphocytic Leukemia Research (64 papers) and Acute Lymphoblastic Leukemia research (64 papers). Ilaria Iacobucci collaborates with scholars based in Italy, United States and Germany. Ilaria Iacobucci's co-authors include Giovanni Martinelli, Charles G. Mullighan, Simona Soverini, Michele Baccarani, Giuseppe Saglio, Fabrizio Pane, Cristina Papayannidis, Gianantonio Rosti, Fausto Castagnetti and Marilina Amabile and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ilaria Iacobucci

155 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic Basis of Acute Lymphoblastic Leukemia

2017 341 citations Ilaria Iacobucci, Charles G. Mullighan Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilaria Iacobucci Italy	33	2.4k	1.5k	1.2k	1.1k	798	165	3.7k
Cristina Papayannidis Italy	26	1.4k 0.6×	508 0.3×	951 0.8×	1.0k 0.9×	194 0.2×	160	2.7k
Rosemary E. Gale United Kingdom	44	5.2k 2.2×	2.3k 1.6×	1.4k 1.2×	3.2k 3.0×	420 0.5×	115	7.4k
Thomas Mercher France	27	2.0k 0.8×	1.9k 1.3×	263 0.2×	2.4k 2.2×	683 0.9×	53	4.0k
Charles Chuah Singapore	28	3.5k 1.5×	2.7k 1.8×	447 0.4×	1.1k 1.0×	1.6k 2.0×	108	4.6k
Christopher A. Eide United States	28	2.3k 1.0×	1.6k 1.1×	293 0.2×	1.6k 1.5×	725 0.9×	97	3.9k
Emanuela Ottaviani Italy	25	1.5k 0.6×	753 0.5×	373 0.3×	1.1k 1.0×	311 0.4×	147	2.4k
Virginie Penard‐Lacronique France	23	977 0.4×	592 0.4×	403 0.3×	1.4k 1.3×	167 0.2×	44	2.8k
RJ Jones United States	24	1.7k 0.7×	688 0.5×	305 0.3×	725 0.7×	180 0.2×	33	2.8k
Anupriya Agarwal United States	28	1.7k 0.7×	1.2k 0.8×	234 0.2×	1.4k 1.3×	418 0.5×	85	3.1k
Gerald M. Segal United States	13	2.5k 1.1×	1.4k 0.9×	281 0.2×	953 0.9×	846 1.1×	20	3.9k

Countries citing papers authored by Ilaria Iacobucci

Since Specialization

Citations

This map shows the geographic impact of Ilaria Iacobucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilaria Iacobucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilaria Iacobucci more than expected).

Fields of papers citing papers by Ilaria Iacobucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilaria Iacobucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilaria Iacobucci. The network helps show where Ilaria Iacobucci may publish in the future.

Co-authorship network of co-authors of Ilaria Iacobucci

This figure shows the co-authorship network connecting the top 25 collaborators of Ilaria Iacobucci. A scholar is included among the top collaborators of Ilaria Iacobucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilaria Iacobucci. Ilaria Iacobucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Andy G.X., Ilaria Iacobucci, Amanda Mitchell, et al.. (2025). Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation. Blood Cancer Discovery. 6(4). 307–324. 8 indexed citations

Iacobucci, Ilaria. (2024). “Myeloid” Mutations in ALL Are Not Uncommon: Implications for Etiology and Therapies. Blood Cancer Discovery. 5(3). 142–145. 2 indexed citations

Zeng, Andy G.X., Ilaria Iacobucci, Amanda Mitchell, et al.. (2024). 2020 – PRECISE SINGLE-CELL TRANSCRIPTOMIC MAPPING OF NORMAL AND LEUKEMIC CELL STATES REVEALS UNCONVENTIONAL LINEAGE PRIMING IN ACUTE MYELOID LEUKEMIA. Experimental Hematology. 137. 104577–104577. 1 indexed citations

Tian, Mi, Andrew G. Soerens, Shanta Alli, et al.. (2024). Conserved epigenetic hallmarks of T cell aging during immunity and malignancy. Nature Aging. 4(8). 1053–1063. 15 indexed citations

Iacobucci, Ilaria & Lindsey E. Montefiori. (2024). Staying in the loop blocks oncogene activation. Blood. 144(22). 2276–2277.

Myers, Jacquelyn, Elodie Henriet, Shondra M. Pruett‐Miller, et al.. (2023). 3138 – EPIGENETIC REGULATORS TET2 AND POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) COORDINATE GENE EXPRESSION IN MYELODYSPLASTIC SYNDROME (MDS). Experimental Hematology. 124. S118–S118.

Oak, Ninad, Ruopeng Feng, Ilaria Iacobucci, et al.. (2023). ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice. Blood Advances. 7(18). 5608–5623. 9 indexed citations

Chang, Yunchao, Gisele Nishiguchi, Qingsong Gao, et al.. (2023). The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia. Blood. 142(7). 629–642. 19 indexed citations

Fontana, Maria Chiara, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.. (2021). Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. Biomedicines. 9(4). 388–388. 9 indexed citations

10.

Dominici, Marco De, Patrizia Porazzi, Angela Rachele Soliera, et al.. (2017). Targeting CDK6 and BCL2 Exploits the “MYB Addiction” of Ph+ Acute Lymphoblastic Leukemia. Cancer Research. 78(4). 1097–1109. 20 indexed citations

11.

Iacobucci, Ilaria & Charles G. Mullighan. (2017). Genetic Basis of Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 35(9). 975–983. 341 indexed citations breakdown →

12.

Falzacappa, Maria Vittoria Verga, Chiara Ronchini, Mario Faretta, et al.. (2015). The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias. Molecular Cancer Therapeutics. 14(4). 889–898. 25 indexed citations

13.

Filì, Carla, Michele Malagola, Matilde Y. Follo, et al.. (2013). Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes. Clinical Cancer Research. 19(12). 3297–3308. 56 indexed citations

14.

Cilloni, Daniela, Sonia Carturan, Enrico Bracco, et al.. (2013). Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia. Leukemia Research. 37(5). 520–530. 13 indexed citations

15.

Sartor, Chiara, Cristina Papayannidis, Maria Chiara Abbenante, et al.. (2013). A Case Report of Acute Myeloid Leukemia and Neurofibromatosis 1. SHILAP Revista de lepidopterología. 5(2). e8–e8. 2 indexed citations

16.

Mijatovic, Vladan, Ilaria Iacobucci, Marco Sazzini, et al.. (2012). Imputation reliability on DNA biallelic markers for drug metabolism studies. BMC Bioinformatics. 13(S14). S7–S7. 6 indexed citations

17.

Cazzaniga, Giovanni, Frederik W. van Delft, Luca Lo Nigro, et al.. (2011). Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood. 118(20). 5559–5564. 67 indexed citations

18.

Martinelli, Giovanni, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.. (2009). IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report. Journal of Clinical Oncology. 27(31). 5202–5207. 219 indexed citations

19.

Martinelli, Giovanni, Ilaria Iacobucci, Daniela Cilloni, et al.. (2009). New drugs to overcome meccanisms of resistance in Ph+ leukemia: bosutinib. 2(5). 27–32. 1 indexed citations

20.

Martinelli, Giovanni, Ilaria Iacobucci, Simona Soverini, et al.. (2007). Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance.. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact